K. Ravi Acharya

15.2k citations

272 papers · 12.0k indexed · 3 hit papers · h-index 58

Co-authors: Edward D. Sturrock Sylva L. U. Schwager R. Natesh Keith Brew Steven J. Ackerman David I. Stuart D.D. Leonidas Kenneth P. Holbourn
Topics: Enzyme Structure and Function (41 papers)Glycosylation and Glycoproteins Research (37 papers)Toxin Mechanisms and Immunotoxins (28 papers)
Cited by: Molecular Biology Immunology Neurology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United Kingdom United States South Africa

In The Last Decade

K. Ravi Acharya

263 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal structure of the human angiotensin-converting enzyme–lisinopril complex

2003 712 citations R. Natesh, Sylva L. U. Schwager et al. profile →
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

2006 518 citations K. Ravi Acharya et al. profile →
Eosinophil Granule Proteins: Form and Function

2014 371 citations K. Ravi Acharya, Steven J. Ackerman Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by K. Ravi Acharya

Since Specialization

Citations

This map shows the geographic impact of K. Ravi Acharya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Ravi Acharya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Ravi Acharya more than expected).

Fields of papers citing papers by K. Ravi Acharya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Ravi Acharya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Ravi Acharya. The network helps show where K. Ravi Acharya may publish in the future.

Co-authorship network of co-authors of K. Ravi Acharya

This figure shows the co-authorship network connecting the top 25 collaborators of K. Ravi Acharya. A scholar is included among the top collaborators of K. Ravi Acharya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Ravi Acharya. K. Ravi Acharya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular basis of human angiotensin‐1 converting enzyme inhibition by a series of diprolyl‐derived compounds 2025 ·FEBS Journal ·(unknown),Gyles E. Cozier,(unknown),Kelly Chibale,Edward D. Sturrock,K. Ravi Acharya	0
2	A mini-review on the international gyrate atrophy symposium 2023: More than meets the eye. Focus on outstanding research questions 2024 ·Molecular Genetics and Metabolism ·Marion M. Brands,(unknown),K. Ravi Acharya,Arthur A. Bergen,Nicola Brunetti‐Pierri,Mark J. Buijs,Barbara Cellini,(unknown),Mandeep Singh,Andreas Schulze,(unknown),David Valle,Ronald J. A. Wanders,Kirmo Wartiovaara,Clara van Karnebeek	1
3	Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors 2024 ·Bioscience Reports ·K. Ravi Acharya,(unknown),Edward D. Sturrock	18
4	Engineering Plastic Eating Enzymes Using Structural Biology 2023 ·Biomolecules ·(unknown),K. Ravi Acharya	14
5	Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR) 2023 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown),K. Ravi Acharya,Matthew D. Lloyd	2
6	Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease 2023 ·FEBS Journal ·Joanna Żukowska,Stephen J. Moss,Vasanta Subramanian,K. Ravi Acharya	14
7	Crystal Structure of the Catalytic Domain of a Botulinum Neurotoxin Homologue from Enterococcus faecium: Potential Insights into Substrate Recognition 2023 ·International Journal of Molecular Sciences ·(unknown),(unknown),(unknown),(unknown),Sai Liu,K. Ravi Acharya	0
8	A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes 2023 ·Toxins ·(unknown),K. Ravi Acharya	7
9	Structural basis for the inhibition of human angiotensin‐1 converting enzyme by fosinoprilat 2022 ·FEBS Journal ·Gyles E. Cozier,(unknown),Sylva L. U. Schwager,R. Elwyn Isaac,Edward D. Sturrock,K. Ravi Acharya	3
10	The catalytic activity and secretion of zebrafish RNases are essential for their in vivo function in motor neurons and vasculature 2019 ·Scientific Reports ·(unknown),Daniel E. Holloway,Anand Chandrasekhar,K. Ravi Acharya,Vasanta Subramanian	9
11	The structure of the S-layer of Clostridium difficile 2017 ·Journal of Cell Communication and Signaling ·W.J. Bradshaw,April K. Roberts,Clifford C. Shone,K. Ravi Acharya	37
12	Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme 2016 ·FEBS Journal ·(unknown),Geoffrey Masuyer,Ross G. Douglas,Sylva L. U. Schwager,K. Ravi Acharya,Edward D. Sturrock	18
13	Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence 2014 ·Biological Chemistry ·Geoffrey Masuyer,Christopher J. Yates,Edward D. Sturrock,K. Ravi Acharya	42
14	Absence of cell surface expression of human ACE leads to perinatal death 2013 ·Human Molecular Genetics ·Annie Michaud,K. Ravi Acharya,Geoffrey Masuyer,Nicole Quenech’Du,Olivier Gribouval,Vincent Morinière,Marie-Claire Gübler,Pierre Corvol	14
15	Crystal Structure of Protoporphyrinogen Oxidase from Myxococcus xanthus and Its Complex with the Inhibitor Acifluorfen 2006 ·Journal of Biological Chemistry ·Hazel Corradi,Anne V. Corrigall,Ester Boix,C. Gopi Mohan,Edward D. Sturrock,Peter N. Meissner,K. Ravi Acharya	57
16	Crystal Structure of an Active Form of Human MMP-1 2006 ·Journal of Molecular Biology ·Shalini Iyer,Robert Visse,Hideaki Nagase,K. Ravi Acharya	88
17	Structural Details on the Binding of Antihypertensive Drugs Captopril and Enalaprilat to Human Testicular Angiotensin I-Converting Enzyme ^, 2004 ·Biochemistry ·R. Natesh,Sylva L. U. Schwager,Hazel R. Evans,Edward D. Sturrock,K. Ravi Acharya	234
18	Ace revisited: A new target for structure-based drug design 2003 ·Nature Reviews Drug Discovery ·K. Ravi Acharya,Edward D. Sturrock,James Riordan,Mario R. Ehlers	259
19	Microbial superantigens: from structure to function 2000 ·Trends in Microbiology ·Anastassios C. Papageorgiou,K. Ravi Acharya,(unknown)	78
20	Crystal structure of human Charcot–Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins 1995 ·Structure ·D.D. Leonidas,(unknown),(unknown),Hakon Leffler,Steven J. Ackerman,K. Ravi Acharya	117

About K. Ravi Acharya

K. Ravi Acharya is a scholar working on Immunology, Molecular Biology and Neurology, having authored 272 papers that have together received 12.0k indexed citations. Recurring topics across this work include Enzyme Structure and Function (41 papers), Glycosylation and Glycoproteins Research (37 papers) and Toxin Mechanisms and Immunotoxins (28 papers). The work is most often cited by research in Molecular Biology (7.1k citations), Immunology (1.9k citations) and Neurology (1.2k citations). K. Ravi Acharya has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Edward D. Sturrock, Sylva L. U. Schwager, R. Natesh, Keith Brew, Steven J. Ackerman, David I. Stuart, D.D. Leonidas, Kenneth P. Holbourn, Shalini Iyer and Anastassios C. Papageorgiou. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact